Dr Reddys Laboratories RDY
NYSE RDY
$11.85 -0.03 (-0.29%)
As of: Sep 9, 2026 · 2:32 PM EDT

Dr Reddys Laboratories (RDY) Other Non-Current Assets (2009 - 2026)

Dr Reddys Laboratories (RDY) posted Other Non-Current Assets of $11.7 million for Q2 2026, down 12.5% on a QoQ basis from $13.4 million in Q1 2026, and up 6.96% year-over-year from $11.0 million in Q2 2025.

Analysis

Dr Reddys Laboratories (RDY) Other Non-Current Assets (2009 - 2026) Analysis & Trends

Dr Reddys Laboratories has reported Other Non-Current Assets for 18 years, with the latest figure at $11.7 million in Q2 2026.

  • On a quarterly basis, Other Non-Current Assets rose 6.96% year-over-year to $11.7 million in Q2 2026; TTM through Jun 2026 was $11.7 million, a 6.96% increase from a year earlier, with the FY2026 full-year figure at $13.0 million, up 8.33% from the prior year.
  • Other Non-Current Assets was $11.7 million for Q2 2026 at Dr Reddys Laboratories, down from $13.4 million in the prior quarter.
  • The five-year high for Other Non-Current Assets was $23.6 million in Q2 2022, with the low at $9.7 million in Q1 2023.
  • Average Other Non-Current Assets over 5 years is $14.9 million, with a median of $12.9 million recorded in 2025.
  • The sharpest annual moves came in 2022 and 2023: Other Non-Current Assets jumped 106.35% in 2022, then tumbled 57.59% in 2023.
  • Over 5 years, Other Non-Current Assets stood at $22.3 million in 2022, then sank by 39.25% to $13.5 million in 2023, then climbed by 18.9% to $16.1 million in 2024, then fell by 23.59% to $12.3 million in 2025, then dropped by 4.65% to $11.7 million in 2026.
  • The last three Other Non-Current Assets figures came in at $11.7 million (Q2 2026), $13.4 million (Q1 2026), and $12.3 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Teva Pharmaceutical Industries 42.63 Bn 38.97 Bn 2.15 Bn 1.79 Bn
2 Viatris 19.19 Bn 18.30 Bn 1.46 Bn 1.06 Bn
3 Dr Reddys Laboratories 9.86 Bn 9.69 Bn 396.53 Mn 11.74 Mn
4 Amneal Pharmaceuticals 5.48 Bn 5.35 Bn 334.51 Mn 80.67 Mn
5 Bausch Health Companies 2.36 Bn 520.30 Mn 2.10 Bn 358.00 Mn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn 14.42 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn 11.62 Mn
8 Amphastar Pharmaceuticals 995.52 Mn 705.40 Mn 93.47 Mn 33.39 Mn
9 Fennec Pharmaceuticals 404.35 Mn 363.10 Mn 17.15 Mn 666,000.00
10 RedHill Biopharma 176.59 Mn 176.59 Mn - 169,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.74 Mn
Mar 31, 2026 13.41 Mn
Dec 31, 2025 12.31 Mn
Sep 30, 2025 12.29 Mn
Jun 30, 2025 10.97 Mn
Mar 31, 2025 11.22 Mn
Dec 31, 2024 16.11 Mn
Sep 30, 2024 18.03 Mn
Jun 30, 2024 19.89 Mn
Mar 31, 2024 19.65 Mn
Dec 31, 2023 13.55 Mn
Sep 30, 2023 9.82 Mn
Jun 30, 2023 9.99 Mn
Mar 31, 2023 9.73 Mn
Dec 31, 2022 22.30 Mn
Sep 30, 2022 22.59 Mn
Jun 30, 2022 23.56 Mn
Mar 31, 2022 11.89 Mn
Dec 31, 2021 12.52 Mn
Sep 30, 2021 11.16 Mn